NYSE Composite ended the session with GlaxoSmithKline rising 4.32% to $37.69 on Friday while nYSE Composite rose 0.73% to $16,116.85.
GlaxoSmithKline today’s close was $37.69, 14.57% under its 52-week high of $43.18.
Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 34.1B for the twelve trailing months.
GlaxoSmithKline’s last day, last week, and last month’s current volatility was 0.25%, 0.72%, and 0.69%, respectively.
GlaxoSmithKline‘s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.94% (day), 0.82% (last week), and 1.09% (last month), respectively.
GlaxoSmithKline’s Stock Yearly Top and Bottom Value
GlaxoSmithKline’s stock is valued at $37.69 at 17:06 EST, way below its 52-week high of $43.18 and way above its 52-week low of $33.26.
GlaxoSmithKline’s Moving Average
GlaxoSmithKline’s worth is above its 50-day moving average of $35.39 and higher than its 200-day moving average of $36.62.
More news about GlaxoSmithKline.